Psychiatric comorbidity and pharmacological treatment patterns among patients presenting with insomnia. An assessment of office-based encounters in the USA in 1995 and 1996

Clinical Drug Investigation

Volumn 18, Issue 2, 1999, Pages 161-167

  Skaer, Tracy L ^a,b   Robison, Linda M ^a   Sclar, David A ^a,c   Galin, Richard S ^a,b,d  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b Pullman Memorial Hospital   (United States)

^c Eastern Branch   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; FLUOXETINE; HYPNOTIC SEDATIVE AGENT; NORTRIPTYLINE; PAROXETINE; SERTRALINE; TRIMIPRAMINE;

ADULT; AGED; ARTICLE; COMORBIDITY; DEPRESSION; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PRIORITY JOURNAL; UNITED STATES;

EID: 0032778676     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199918020-00009     Document Type: Article

References (33)

1. 1. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 1989; 262: 1479-84
2. 2. Quera-Salva MA, Orluc A, Goldenberg F, et al. Insomnia and use of hypnotics: study of a French population. Sleep 1991; 14: 386-9 1
3. 3. Katz DA, McHorney CA. Clinical correlates of insomnia in patients with chronic illness. Arch Intern Med 1998; 158: 1099-107
4. 4 Soldatos CR. Insomnia in relation to depression and anxiety: epidemiologic considerations. J Psychosom Res 1994; 38 Suppl. 1: 3-8
5. 5. Ohayon MM. Prevalence of DSM-IV diagnostic criteria of insomnia: distinguishing insomnia related to mental disorders from sleep disorders. J Psychiatr Res 1997; 31: 333-46
6. 6. Schramm E, Hohagen F, Kappler C, et al. Mental comorbidity of chronic insomnia in general practice attenders using DSM-III-R. Acta Psychiatr Scand 1995; 91: 10-7
7. 7. Simon GE, VonKorff M. Prevalence, burden, and treatment of insomnia in primary care. Am J Psychiatry 1997; 154: 1417-23
8. 8. National Sleep Foundation. 1998 Omnibus Sleep in America Poll. http://206.215.227.10/nsf/publications/1998poll.html [accessed 1999 Jul 12]
9. 9. Ohayon MM, Caulet M, Lemoine P. Comorbidity of mental and insomnia disorders in the general population. Compr Psychiatry 1998; 39: 185-97
10. 10. Eaton WE, Badawi M, Melton B. Prodromes and precursors: epidemiologic data for primary prevention of disorders with slow onset. Am J Psychiatry 1995; 152: 967-72
11. 11. Kupfer DJ, Reynolds CF. Management of insomnia. N Engl J Med 1997; 336: 341-6
12. 12. Weissman MM, Greenwald S, Nino-Murcia G, et al. The morbidity of insomnia uncomplicated by psychiatric disorders. Gen Hosp Psychiatry 1997; 19: 245-50
13. 13. Radecki SE, Brunton SA. Management of insomnia in office-based practice. Arch Fam Med 1993; 2: 1129-34
14. 14. Woodwell DA. National Ambulatory Medical Care Survey, 1995 summary. Advance Data from Vital and Health Statistics. No. 286. Hyattsville, MD: National Center for Health Statistics, 1997
15. 15. Woodwell DA. National Ambulatory Medical Care Survey, 1996 summary. Advance Data from Vital and Health Statistics. No. 295. Hyattsville, MD: National Center for Health Statistics, 1997
16. 16. Bryant E, Shimizu I. Sampling design, sampling variance, and estimation procedures for the National Ambulatory Medical Care Survey. National Center for Health Statistics, Vital Health Stat 1988; 2: 1-39
17. 17. Schneider D, Appleton L, McLemore T. A reason for visit classification for ambulatory care. National Center for Health Statistics. Vital Health Stat 1979; 2: 1-63
18. 18. Instruction Manual: Reason for Visit Classification and Coding Manual, 1994. National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey. Hyattsville, MD: National Center for Health Statistics, 1995
19. 19. US Public Health Service and Health Care Financing Administration. The International Classification of Diseases. 9th revision. Clinical Modification, Volume 1. DHHS Publication No. (PHS) 89-1260. Washington: Public Health Service, March 1989
20. 20. Food and Drug Administration. National Drug Code Directory. 1995 ed. Washington: Public Health Service, 1995
21. 21. Koch H, Campbell W. The collection and processing of drug information. National Ambulatory Medical Care Survey, 1980. National Center for Health Statistics, Vital Health Stat 1982; 2: 1-90
22. 22. SETS. Statistical Export and Tabulation System 1.22a: Users Reference Manual, United States Department of Health and Human Services, National Center for Health Statistics, 1991
23. 23. Nino-Murcia G. Diagnosis and treatment of insomnia and risks associated with lack of treatment. J Clin Psychiatry 1992; 53 Suppl.: 43-7
24. 24. The Gallup Organization. Sleep in America: a National Survey of US Adults. Los Angeles, CA: National Sleep Foundation, 1991
25. 25. Silva J, Chase M, Sartorius N, et al. Special report from a symposium held by the World Health Organisation and the World Federation of Sleep Research Societies: an overview of insomnias and related disorders - recognition, epidemiology, and rational management. Sleep 1996; 19: 412-6
26. 26. US Census Bureau. National population estimates for the 1990s. Monthly postcensal resident population, by single year of age, sex, race, and Hispanic origin. Published 1998 Feb 22 http://www.census.gov/population/www/estimates/ nat_90s_1.html [accessed 1999 Jul 12]
27. 27. Hartmann PM. Drug treatment of insomnia: indications and newer agents. Am Fam Physician 1995; 51: 191-4
28. 28. Ware JC, Morewitz J. Diagnosis and treatment of insomnia and depression. J Clin Psychiatry 1991; 52 Suppl.: 55-61
29. 29. Gillin JC. Are sleep disturbances risk factors for anxiety, depressive and addictive disorders? Acta Psychiatr Scand 1998; 393 Suppl.: 39-43
30. 30. Foley DJ, Monjan AA, Brown SL, et al. Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep 1995; 18: 425-32
31. 31. Mellinger GD, Balter MB, Uhlenhuth EH. Insomnia and its treatment. Prevalence and correlates. Arch Gen Psychiatry 1985; 42: 225-32
32. 32. Ohayon MM. DSM-IV and ICSD-90 insomnia symptoms and sleep dissatisfaction. Br J Psychiatry 1997; 171: 382-8
33. 33. Hatoum HT, Kong SX, Kania CM, et al. Insomnia, health-related quality of life, and healthcare resource consumption: a study of managed care organization enrollees. Pharmacoeconomics 1998; 14: 629-37